Praxair, Inc. (PX) Reports In-Line Q2 EPS; Trims FY12 Expectations; Guides Q3 EPS
Tweet
Share
E-mailGet Alerts PX Hot Sheet
Price: $10.54 --0%
Financial Fact:
Brazil tax amnesty program and other charges: 100M
Today's EPS Names:
PLCE, COE, JVA, More
Financial Fact:
Brazil tax amnesty program and other charges: 100M
Today's EPS Names:
PLCE, COE, JVA, More
Join SI Premium – FREE
Praxair, Inc. (NYSE: PX) reported Q2 EPS of $1.42, in-line with the analyst estimate of $1.42. Revenue for the quarter came in at $2.8 billion versus the consensus estimate of $2.93 billion.
Praxair, Inc. sees FY2012 EPS of $5.60-$5.70, versus prior guidance of $5.75-$5.90 and the consensus of $5.79. Praxair, Inc. sees FY2012 revenue of $11.2-$11.5 million, versus prior guidance of $11.6-$11.9 million and the consensus of $11.73 million.
Praxair, Inc. sees Q3 2012 EPS of $1.35-$1.40, versus the consensus of $1.49.
For earnings history and earnings-related data on Praxair, Inc. (PX) click here.
Praxair, Inc. sees FY2012 EPS of $5.60-$5.70, versus prior guidance of $5.75-$5.90 and the consensus of $5.79. Praxair, Inc. sees FY2012 revenue of $11.2-$11.5 million, versus prior guidance of $11.6-$11.9 million and the consensus of $11.73 million.
Praxair, Inc. sees Q3 2012 EPS of $1.35-$1.40, versus the consensus of $1.49.
For earnings history and earnings-related data on Praxair, Inc. (PX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nvidia pitches Vera CPU to Chinese clients with August delivery target
- RH (RH) Tops Q1 EPS by 12c
- Aspire Biopharma to acquire automotive supplier for $30 million
Create E-mail Alert Related Categories
Earnings, Guidance, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
